Hyperkalemic periodic paralysis: genes and variants
Explore variant evidence for Hyperkalemic periodic paralysis across 2 analyzed proteins (SCN4A, CLCN1). Linked ClinVar records include 63 pathogenic or likely pathogenic variants, 710 variants of uncertain significance and 55 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Hyperkalemic periodic paralysis
SCN4A: Sodium channel protein type 4 subunit alpha
Its rapid sodium current initiates and propagates skeletal-muscle action potentials. Gain- and loss-of-function variants cause disorders of muscle excitability including sodium-channel myotonia, paramyotonia congenita, periodic paralysis, and some congenital myopathies.
62 ClinVar pathogenic / likely pathogenic and 765 uncertain variants in SCN4A have source records linked to Hyperkalemic periodic paralysis. Association strength is not clinical gene validity.
CLCN1: Chloride channel protein 1
Its chloride conductance stabilizes the resting membrane potential of skeletal muscle and prevents repetitive firing after contraction. Loss-of-function variants cause myotonia congenita, with delayed muscle relaxation and stiffness.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CLCN1 have source records linked to Hyperkalemic periodic paralysis. Association strength is not clinical gene validity.
Where Hyperkalemic periodic paralysis variants cluster
- SCN4A S4 of repeat II (positions 665–682): 7 of 61 ClinVar pathogenic / likely pathogenic variants, 11.7× more than its size predicts (a length-based count, not a validated hotspot).
- SCN4A Cytoplasmic (positions 1463–1481): 7 of 61 ClinVar pathogenic / likely pathogenic variants, 11.1× more than its size predicts (a length-based count, not a validated hotspot).
- SCN4A S4 of repeat IV (positions 1446–1462): 6 of 61 ClinVar pathogenic / likely pathogenic variants, 10.6× more than its size predicts (a length-based count, not a validated hotspot).
- SCN4A Cytoplasmic (positions 1143–1159): 4 of 61 ClinVar pathogenic / likely pathogenic variants, 7.1× more than its size predicts (a length-based count, not a validated hotspot).
- SCN4A S1 of repeat IV (positions 1355–1372): 4 of 61 ClinVar pathogenic / likely pathogenic variants, 6.7× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Hyperkalemic periodic paralysis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SCN4A L250P | 250 | I | Pathogenic / likely pathogenic (★★) |
| SCN4A V445M | 445 | I | Pathogenic / likely pathogenic (★★) |
| SCN4A V445L | 445 | I | Pathogenic / likely pathogenic (★★) |
| SCN4A A1156S | 1156 | III | Pathogenic / likely pathogenic (★★) |
| SCN4A T1313M | 1313 | III | Pathogenic / likely pathogenic (★★) |
| SCN4A M1370V | 1370 | IV | Pathogenic / likely pathogenic (★★) |
| SCN4A M1476I | 1476 | IV | Pathogenic / likely pathogenic (★★) |
| SCN4A R672C | 672 | II | Pathogenic / likely pathogenic (★★) |
| SCN4A R672G | 672 | II | Pathogenic / likely pathogenic (★★) |
| SCN4A R672S | 672 | II | Pathogenic / likely pathogenic (★★) |
| SCN4A R675G | 675 | II | Pathogenic / likely pathogenic (★★) |
| SCN4A R675W | 675 | II | Pathogenic / likely pathogenic (★★) |
| SCN4A I693T | 693 | II | Pathogenic / likely pathogenic (★★) |
| SCN4A A1156T | 1156 | III | Pathogenic / likely pathogenic (★★) |
| SCN4A P1158S | 1158 | III | Pathogenic / likely pathogenic (★★) |
| SCN4A P1158L | 1158 | III | Pathogenic / likely pathogenic (★★) |
| SCN4A R1448P | 1448 | IV | Pathogenic / likely pathogenic (★★) |
| SCN4A R1463S | 1463 | IV | Pathogenic / likely pathogenic (★★) |
| SCN4A M1476T | 1476 | IV | Pathogenic / likely pathogenic (★★) |
| SCN4A M1476V | 1476 | IV | Pathogenic / likely pathogenic (★★) |
| SCN4A R222Q | 222 | I | Pathogenic / likely pathogenic (★★) |
| SCN4A S804F | 804 | II | Pathogenic / likely pathogenic (★★) |
| SCN4A M1360V | 1360 | IV | Pathogenic / likely pathogenic (★★) |
| SCN4A L1436P | 1436 | IV | Pathogenic / likely pathogenic (★★) |
| SCN4A R1454W | 1454 | IV | Pathogenic / likely pathogenic (★★) |
| SCN4A V1458F | 1458 | IV | Pathogenic / likely pathogenic (★★) |
| SCN4A I692M | 692 | II | Pathogenic / likely pathogenic (★★) |
| SCN4A R1135C | 1135 | III | Pathogenic / likely pathogenic (★★) |
| SCN4A R1142Q | 1142 | III | Pathogenic / likely pathogenic (★★) |
| SCN4A I1310N | 1310 | III | Pathogenic / likely pathogenic (★★) |
| SCN4A I1455T | 1455 | IV | Pathogenic / likely pathogenic (★★) |
| SCN4A L1461P | 1461 | IV | Pathogenic / likely pathogenic (★★) |
| SCN4A I1160V | 1160 | III | Pathogenic / likely pathogenic (★★) |
| SCN4A G1306V | 1306 | III | Pathogenic / likely pathogenic (★★) |
| SCN4A A1152D | 1152 | III | Pathogenic / likely pathogenic (★★) |
| SCN4A M1592I | 1592 | IV | Pathogenic / likely pathogenic (★★) |
| SCN4A Q1633E | 1633 | IV | Pathogenic / likely pathogenic (★★) |
| SCN4A E1702K | 1702 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SCN4A F1705I | 1705 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SCN4A R1463L | 1463 | IV | Pathogenic / likely pathogenic (★) |
| SCN4A I693S | 693 | II | Pathogenic / likely pathogenic (★) |
| SCN4A T1313A | 1313 | III | Pathogenic / likely pathogenic (★) |
| SCN4A R1448G | 1448 | IV | Pathogenic / likely pathogenic (★) |
| SCN4A R669C | 669 | II | Pathogenic / likely pathogenic (★) |
| SCN4A S1434P | 1434 | IV | Pathogenic / likely pathogenic (★) |
| SCN4A R1463H | 1463 | IV | Pathogenic / likely pathogenic (★) |
| SCN4A L250R | 250 | I | Pathogenic / likely pathogenic (★) |
| SCN4A A444D | 444 | I | Pathogenic / likely pathogenic (★) |
| SCN4A F671C | 671 | II | Pathogenic / likely pathogenic (★) |
| SCN4A M1370T | 1370 | IV | Pathogenic / likely pathogenic (★) |
| SCN4A M203K | 203 | I | Pathogenic / likely pathogenic (★) |
| SCN4A I239V | 239 | I | Pathogenic / likely pathogenic (★) |
| SCN4A Q270K | 270 | I | Pathogenic / likely pathogenic (★) |
| SCN4A N440K | 440 | I | Pathogenic / likely pathogenic (★) |
| SCN4A I588V | 588 | II | Pathogenic / likely pathogenic (★) |
| SCN4A T592I | 592 | II | Pathogenic / likely pathogenic (★) |
| SCN4A A715P | 715 | II | Pathogenic / likely pathogenic (★) |
| SCN4A V1293L | 1293 | III | Pathogenic / likely pathogenic (★) |
| SCN4A N1366K | 1366 | IV | Pathogenic / likely pathogenic (★) |
| SCN4A A1481D | 1481 | IV | Pathogenic / likely pathogenic (★) |
Showing 60 of 63.
Uncertain variants prioritized for review in Hyperkalemic periodic paralysis
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| SCN4A A715T | 715 | II | Conflicting reports (★) | +7: A715P at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.932 |
| SCN4A R1454Q | 1454 | IV | Uncertain (★) | +7: 2 other pathogenic changes within 3 positions; R1454W at the same position is pathogenic; seen in 2.7e-06 of gnomAD DNA copies; REVEL 0.910 |
| SCN4A R1463C | 1463 | IV | Uncertain (★) | +7: 4 other pathogenic changes within 3 positions; R1463L at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.887 |
| SCN4A S1434Y | 1434 | IV | Uncertain (★) | +7: 2 other pathogenic changes within 3 positions; S1434P at the same position is pathogenic; seen in 7e-07 of gnomAD DNA copies; REVEL 0.897 |
| SCN4A F1705L | 1705 | Cytoplasmic | Uncertain (★) | +7: 2 other pathogenic changes within 3 positions; F1705I at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.876 |
| SCN4A R1448L | 1448 | IV | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R1448P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97 |
| SCN4A I1455S | 1455 | IV | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; I1455T at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
| SCN4A E1702V | 1702 | Cytoplasmic | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; E1702K at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.95 |
| SCN4A M1493V | 1493 | IV | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; M1493I at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.83 |
Which prediction tools work for Hyperkalemic periodic paralysis
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MetaLR: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 98 out of 100
- EVE: 96 out of 100
- MetaSVM: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 96 out of 100
- REVEL: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 95 out of 100
- CADD: 95 out of 100
- PolyPhen-2: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 82 out of 100
- SpliceAI: 50 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 46 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Paramyotonia congenita of Von Eulenburg also has ClinVar records linked to SCN4A variants; they fall partly in the same places as the Hyperkalemic periodic paralysis variants (15 pathogenic / likely pathogenic).
- Potassium-aggravated myotonia also has ClinVar records linked to SCN4A variants; they fall in the same places as the Hyperkalemic periodic paralysis variants (14 pathogenic / likely pathogenic).
- Hypokalemic periodic paralysis also has ClinVar records linked to SCN4A variants; they fall in the same places as the Hyperkalemic periodic paralysis variants (11 pathogenic / likely pathogenic).
- Congenital myopathy 22A, classic also has ClinVar records linked to SCN4A variants; they fall in the same places as the Hyperkalemic periodic paralysis variants (8 pathogenic / likely pathogenic).
- Myasthenic syndrome also has ClinVar records linked to SCN4A variants; they fall partly in the same places as the Hyperkalemic periodic paralysis variants (7 pathogenic / likely pathogenic).
- Myotonia, autosomal dominant form also has ClinVar records linked to CLCN1 variants; they fall mostly in different places as the Hyperkalemic periodic paralysis variants (92 pathogenic / likely pathogenic).
- Congenital myotonia, autosomal recessive form also has ClinVar records linked to CLCN1 variants; they fall mostly in different places as the Hyperkalemic periodic paralysis variants (90 pathogenic / likely pathogenic).
- Skeletal muscle channelopathy also has ClinVar records linked to CLCN1 variants; they fall mostly in different places as the Hyperkalemic periodic paralysis variants (11 pathogenic / likely pathogenic).
Diseases related to Hyperkalemic periodic paralysis
- Hypokalemic periodic paralysis, also linked to CLCN1 and SCN4A
- Skeletal muscle channelopathy, also linked to CLCN1 and SCN4A
- Migraine, also linked to CLCN1 and SCN4A
- Amyotrophic lateral sclerosis, also linked to SCN4A
- Myotonia, autosomal dominant form, also linked to CLCN1
- Congenital myotonia, autosomal recessive form, also linked to CLCN1
- Cardiac arrhythmia, also linked to SCN4A
- Sotos syndrome, also linked to SCN4A
- Myasthenic syndrome, also linked to SCN4A
- Epilepsy, also linked to SCN4A
- Paramyotonia congenita of Von Eulenburg, also linked to SCN4A
- Potassium-aggravated myotonia, also linked to SCN4A
Frequently asked questions
Which genes have records linked to Hyperkalemic periodic paralysis?
This view contains 2 analyzed proteins: SCN4A, CLCN1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 63 pathogenic or likely pathogenic variants, 710 variants of uncertain significance and 55 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 9 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 843 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center